1-10 of 10 results for house:"House of Lords"
Librarians' tools
- Search time
- 0.332 seconds
- Solr query time
- 0.003 seconds
- Search query
- house:"House of Lords"
- We searched for
- legislature_ses:25277
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask His Majesty's Government what action they are taking to enforce the ban on the sale and use of illegally modified e-bikes, referred to as "fake e-bikes" in the report by the All-Party Parliamentary Group for Cycling and Walking, Unregulated and Unsafe: The Threat of Illegal E-Bikes, published on 16 June.
To ask His Majesty's Government what action they are taking to enforce the ban on the sale and use of illegally modified e-bikes, referred to as "fake e-bikes" in the report by the All-Party Parliamentary Group for Cycling and Walking, Unregulated and Unsafe: The Threat of Illegal E-Bikes, published on 16 June.
I thank the APPG for their report into this important topic, on which there is cross-Government work to tackle the issues raised and make sure e-bikes are safe to buy and use. Our product safety framework makes clear that consumer products can only be placed on the UK market if they are safe and comply with relevant laws. Businesses, including those modifying or servicing electric bikes, have responsibilities for the safety of those products. The Office for Product Safety and Standards and local authorities enforce the regulations.
E-bikes used illegally on public land is an enforcement matter for the police.
To ask His Majesty's Government, further to the Written Answer by Baroness Jones of Whitchurch on 11 June (HL7370), what discussions they have had with the pharmaceutical industry about tariffs imposed by the United States of America.
To ask His Majesty's Government, further to the Written Answer by Baroness Jones of Whitchurch on 11 June (HL7370), what discussions they have had with the pharmaceutical industry about tariffs imposed by the United States of America.
The Prime Minister, the Secretary of State for Business and Trade and other Ministers, as well as officials from my department and across government have been engaging widely with business organisations and companies from across the economy, including those in the pharmaceuticals sector.
We received a number of responses from the pharmaceuticals sector to DBT's Request for Input launched on 3 April to inform our response to US tariffs.
We will continue our extensive engagement with pharmaceutical businesses from across the UK throughout negotiations, ensuring that their perspectives on the challenges and opportunities are fully understood.
To ask His Majesty's Government, further to the Written Answer by Baroness Jones of Whitchurch on 11 June (HL7370), what representations they have received from the pharmaceutical industry about tariffs imposed by the United States of America.
To ask His Majesty's Government, further to the Written Answer by Baroness Jones of Whitchurch on 11 June (HL7370), what representations they have received from the pharmaceutical industry about tariffs imposed by the United States of America.
The Prime Minister, the Secretary of State for Business and Trade and other Ministers, as well as officials from my department and across government have been engaging widely with business organisations and companies from across the economy, including those in the pharmaceuticals sector.
We received a number of responses from the pharmaceuticals sector to DBT's Request for Input launched on 3 April to inform our response to US tariffs.
We will continue our extensive engagement with pharmaceutical businesses from across the UK throughout negotiations, ensuring that their perspectives on the challenges and opportunities are fully understood.
To ask His Majesty's Government what protections, if any, they have secured for the UK pharmaceutical industry in relation to the imposition of tariffs by the United States of America.
To ask His Majesty's Government what protections, if any, they have secured for the UK pharmaceutical industry in relation to the imposition of tariffs by the United States of America.
On 8 May, the UK government announced a landmark economic deal with the United States, making the UK the first country to get an agreement with President Trump.
The agreement will secure the UK preferential access to the US market for UK pharmaceuticals in case of new US tariffs being introduced in the future, further to any section 232 investigations. These conversations are ongoing, and we will work closely with the US administration to get the best deal for our pharma industry.
To ask His Majesty's Government what representations they have made to the governments of (1) China, and (2) the United States of America, regarding the introduction of trade tariffs.
To ask His Majesty's Government what representations they have made to the governments of (1) China, and (2) the United States of America, regarding the introduction of trade tariffs.
We have concluded a landmark economic deal with the United States, making the UK the first country to reach an agreement with President Trump. This deal protects jobs in the automotive, steel, aluminium, pharmaceutical and aerospace sectors - sectors that employ over 320,000 people across the UK. We are continuing talks on a wider UK-US Economic Deal which will look at increasing digital trade, access for our world-leading services industries and improving supply chains.
In April, Minister Alexander travelled to Beijing where he met ministers from the Ministry of Commerce and Ministry of Industry and Information Technology to discuss a range of bilateral and global trade issues, including the trade tariffs.
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
Lords motion to approve. Agreed to on question.
Lords motion to approve. Agreed to on question.